$DMTKQ
DermTech Inc

2022 Q1 Form 10-K Financial Statement

#000156459022009635 Filed on March 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 2020 Q4
Revenue $3.718M $11.84M $2.120M
YoY Change 47.31% 101.16% 33.33%
Cost Of Revenue $3.554M $10.56M $1.730M
YoY Change 77.52% 76.66% 44.17%
Gross Profit $164.0K $1.274M $400.0K
YoY Change -68.58% -1427.08% 2.56%
Gross Profit Margin 4.41% 10.76% 18.87%
Selling, General & Admin $24.02M $62.41M $7.950M
YoY Change 105.55% 108.73% 63.92%
% of Gross Profit 14644.51% 4898.82% 1987.5%
Research & Development $6.338M $16.26M $1.910M
YoY Change 181.56% 207.22% 193.85%
% of Gross Profit 3864.63% 1276.37% 477.5%
Depreciation & Amortization $372.0K $1.000M $180.0K
YoY Change 95.79% 100.0% 500.0%
% of Gross Profit 226.83% 78.49% 45.0%
Operating Expenses $30.36M $78.67M $9.860M
YoY Change 117.83% 123.54% 79.27%
Operating Profit -$30.19M -$77.40M -$9.460M
YoY Change 125.09% 119.33% 85.13%
Interest Expense $66.00K $151.0K $20.00K
YoY Change 94.12% 277.5%
% of Operating Profit
Other Income/Expense, Net $83.00K -$1.088M -$1.260M
YoY Change -105.02% -8.42%
Pretax Income -$30.11M -$78.34M -$9.440M
YoY Change 99.79% 122.23% 84.38%
Income Tax
% Of Pretax Income
Net Earnings -$30.11M -$78.34M -$9.440M
YoY Change 99.81% 114.75% 84.38%
Net Earnings / Revenue -809.79% -661.72% -445.28%
Basic Earnings Per Share -$1.01 -$2.71
Diluted Earnings Per Share -$1.009M -$2.712M -$478.9K
COMMON SHARES
Basic Shares Outstanding 29.85M 28.88M shares 19.60M
Diluted Shares Outstanding 29.84M shares 28.88M shares

Balance Sheet

Concept 2022 Q1 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $199.1M $225.3M $63.80M
YoY Change -22.89% 253.18% 314.29%
Cash & Equivalents $145.1M $176.9M $24.25M
Short-Term Investments $54.05M $48.45M $39.50M
Other Short-Term Assets $723.0K $3.166M $79.00K
YoY Change 113.27% 111.07% 216.0%
Inventory $763.0K $480.0K $104.0K
Prepaid Expenses
Receivables $4.995M $3.847M $1.480M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $208.1M $232.8M $66.88M
YoY Change -20.47% 248.02% 289.98%
LONG-TERM ASSETS
Property, Plant & Equipment $5.141M $12.29M $2.731M
YoY Change 65.84% 355.3% 179.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.192M $3.192M $167.0K
YoY Change 1496.0% 1496.0% 98.81%
Total Long-Term Assets $31.40M $15.49M $2.898M
YoY Change 851.45% 433.97% 173.14%
TOTAL ASSETS
Total Short-Term Assets $208.1M $232.8M $66.88M
Total Long-Term Assets $31.40M $15.49M $2.898M
Total Assets $239.5M $248.3M $69.78M
YoY Change -9.61% 255.74% 283.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.575M $2.880M $1.573M
YoY Change -39.42% 80.0% -2.24%
Accrued Expenses $3.041M $7.800M $763.0K
YoY Change 1.37% 178.57% 250.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $112.0K $121.0K $100.0K
YoY Change 12.0% 21.0%
Total Short-Term Liabilities $14.42M $12.18M $5.425M
YoY Change 103.15% 125.57% -5.19%
LONG-TERM LIABILITIES
Long-Term Debt $105.0K $136.0K $200.0K
YoY Change -47.5% -32.0%
Other Long-Term Liabilities $21.51M $6.294M $600.0K
YoY Change 2290.22% 949.0%
Total Long-Term Liabilities $21.62M $6.430M $800.0K
YoY Change 1865.18% 703.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.42M $12.18M $5.425M
Total Long-Term Liabilities $21.62M $6.430M $800.0K
Total Liabilities $36.04M $18.61M $7.940M
YoY Change 339.52% 195.41% 25.04%
SHAREHOLDERS EQUITY
Retained Earnings -$236.5M -$128.0M
YoY Change 39.84%
Common Stock $440.6M $189.9M
YoY Change 83.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $203.5M $229.7M $61.84M
YoY Change
Total Liabilities & Shareholders Equity $239.5M $248.3M $69.78M
YoY Change -9.61% 255.74% 283.18%

Cashflow Statement

Concept 2022 Q1 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$30.11M -$78.34M -$9.440M
YoY Change 99.81% 114.75% 84.38%
Depreciation, Depletion And Amortization $372.0K $1.000M $180.0K
YoY Change 95.79% 100.0% 500.0%
Cash From Operating Activities -$24.82M -$62.11M -$6.740M
YoY Change 131.64% 116.52% 10.86%
INVESTING ACTIVITIES
Capital Expenditures $646.0K $2.720M -$250.0K
YoY Change 5283.33% 48.31% 56.25%
Acquisitions
YoY Change
Other Investing Activities -$6.887M -$9.792M -$2.600M
YoY Change 3343.5% -75.22%
Cash From Investing Activities -$7.533M -$12.51M -$2.860M
YoY Change 3403.72% -69.73% 1687.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 527.0K 230.3M 19.23M
YoY Change -99.74% 191.87% 11211.76%
NET CHANGE
Cash From Operating Activities -24.82M -62.11M -6.740M
Cash From Investing Activities -7.533M -12.51M -2.860M
Cash From Financing Activities 527.0K 230.3M 19.23M
Net Change In Cash -31.83M 155.7M 9.630M
YoY Change -116.38% 1654.1% -258.65%
FREE CASH FLOW
Cash From Operating Activities -$24.82M -$62.11M -$6.740M
Capital Expenditures $646.0K $2.720M -$250.0K
Free Cash Flow -$25.47M -$64.83M -$6.490M
YoY Change 137.41% 112.42% 9.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y3M29D
CY2021Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M2D
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2021 dei Trading Symbol
TradingSymbol
DMTK
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29850730
CY2021 dei Auditor Firm
AuditorFirmId
185
CY2021 dei Auditor Name
AuditorName
KPMG LLP
CY2021 dei Auditor Location
AuditorLocation
San Diego, CA
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
176882000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24248000
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
48449000
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
39529000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3847000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1480000
CY2021Q4 us-gaap Inventory Net
InventoryNet
480000
CY2020Q4 us-gaap Inventory Net
InventoryNet
104000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1521000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
232824000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
66882000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4549000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2731000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7744000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3025000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
167000
CY2021Q4 us-gaap Assets
Assets
248309000
CY2020Q4 us-gaap Assets
Assets
69780000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2880000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1573000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5120000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2075000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
167000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3166000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1227000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
763000
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1380000
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
905000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1453000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
121000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
109000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12181000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5425000
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
146000
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1650000
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
639000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
136000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
226000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6148000
CY2021Q4 us-gaap Liabilities
Liabilities
18611000
CY2020Q4 us-gaap Liabilities
Liabilities
7940000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29772922
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29772922
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20740413
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20740413
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
436183000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
189868000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-124000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-206364000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128029000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
229698000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
61840000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
248309000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69780000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3364000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
37575000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16261000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5293000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24836000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13823000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8865000
CY2021 us-gaap Operating Expenses
OperatingExpenses
78672000
CY2020 us-gaap Operating Expenses
OperatingExpenses
35193000
CY2019 us-gaap Operating Expenses
OperatingExpenses
17665000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-77398000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-35289000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-17605000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
151000
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
40000
CY2019 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2657000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1088000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1228000
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
441000
CY2019 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
355000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2525000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-36477000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-20130000
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28884874
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16979411
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7005037
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.71
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.15
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.87
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-123000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-78458000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36478000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20130000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-5355000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
934000
CY2019 dmtk Adjustments To Additional Paid In Capital Assumed In Business Combination
AdjustmentsToAdditionalPaidInCapitalAssumedInBusinessCombination
420000
CY2019 dmtk Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Convertible Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfConvertiblePreferredStock
4000000
CY2019 dmtk Reclassification Of Stockholders Equity To Warrant Liability
ReclassificationOfStockholdersEquityToWarrantLiability
-187000
CY2019 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
-1569000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1304000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-20130000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11861000
CY2020 dmtk Adjustments To Additional Paid In Capital Issuance Of Series B1 Convertible Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesB1ConvertiblePreferredStock
30968000
CY2020 dmtk Adjustments To Additional Paid In Capital Issuance Of Series B2 Convertible Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesB2ConvertiblePreferredStock
5071000
CY2020 dmtk Stock Issued During Period Value Stock Options Exercised And Rsu Release
StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease
473000
CY2020 dmtk Stock Issued During Period Value Common Stock Warrants Exercised
StockIssuedDuringPeriodValueCommonStockWarrantsExercised
842000
CY2020 dmtk Adjustments To Additional Paid In Capital Issuance Cost Related To Registration
AdjustmentsToAdditionalPaidInCapitalIssuanceCostRelatedToRegistration
-77000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1000
CY2020 dmtk Reclassification Of Warrant Liability Due To Private Spac Warrants Not Held By Original Holder
ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder
206000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
61840000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
134582000
CY2021 dmtk Stock Issued During Period Value Stock Options Exercised And Rsu Release
StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease
793000
CY2021 dmtk Stock Issued During Period Value Common Stock Warrants Exercised
StockIssuedDuringPeriodValueCommonStockWarrantsExercised
72429000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
966000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-123000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13276000
CY2021 dmtk Reclassification Of Warrant Liability Due To Private Spac Warrants Not Held By Original Holder
ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder
434000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-78335000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
229698000
CY2021 us-gaap Profit Loss
ProfitLoss
-78335000
CY2020 us-gaap Profit Loss
ProfitLoss
-36477000
CY2019 us-gaap Profit Loss
ProfitLoss
-20130000
CY2021 us-gaap Depreciation
Depreciation
997000
CY2020 us-gaap Depreciation
Depreciation
486000
CY2019 us-gaap Depreciation
Depreciation
89000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1088000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1228000
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
441000
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
928000
CY2019 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
355000
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1983000
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1299000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
13276000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
4969000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
1304000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-749000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
21000
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-15000
CY2020 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-13000
CY2019 dmtk Payment In Connection With Restricted Stock Unit Release
PaymentInConnectionWithRestrictedStockUnitRelease
1569000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
100000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
69000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1700000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
487000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1069000
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1443000
CY2021 dmtk Increase Decrease In Accounts Payable And Accrued Compensation
IncreaseDecreaseInAccountsPayableAndAccruedCompensation
4335000
CY2020 dmtk Increase Decrease In Accounts Payable And Accrued Compensation
IncreaseDecreaseInAccountsPayableAndAccruedCompensation
827000
CY2019 dmtk Increase Decrease In Accounts Payable And Accrued Compensation
IncreaseDecreaseInAccountsPayableAndAccruedCompensation
1337000
CY2021 dmtk Increase Decrease In Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue
356000
CY2020 dmtk Increase Decrease In Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue
1647000
CY2019 dmtk Increase Decrease In Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue
491000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-62106000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28684000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17791000
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
48092000
CY2020 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
41706000
CY2021 dmtk Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
1600000
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
36700000
CY2020 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2200000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2720000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1834000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
210000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12512000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-41340000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-210000
CY2020 dmtk Payment For Deferred Underwriting Fees
PaymentForDeferredUnderwritingFees
1363000
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
77000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
19802000
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
70271000
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
842000
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
793000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
473000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
929000
CY2021 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
966000
CY2019 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2600000
CY2019 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-516000
CY2019 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
4000000
CY2021 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
171000
CY2020 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
9000
CY2019 dmtk Proceeds Received From Close Of Business Combination
ProceedsReceivedFromCloseOfBusinessCombination
1802000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
230277000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
78898000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28622000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
155659000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8874000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10621000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24248000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15374000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4753000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
179907000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24248000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15374000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
17000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
2000
CY2020 dmtk Issuance Of Common Stock In Litigation Settlement
IssuanceOfCommonStockInLitigationSettlement
1011000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
17000
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
71000
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
641000
CY2021 dmtk Reclassification Of Warrant Liability Due To Private Spac Warrants Not Held By Original Holder
ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder
434000
CY2020 dmtk Reclassification Of Warrant Liability Due To Private Spac Warrants Not Held By Original Holder
ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder
206000
CY2021 dmtk Cashless Exercise Of Common Stock Warrants
CashlessExerciseOfCommonStockWarrants
2158000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9044000
CY2021 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
93000
CY2020 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
342000
CY2021 dmtk Change In Unrealized Gain Loss On Available For Sale Marketable Securities
ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities
-123000
CY2020 dmtk Change In Unrealized Gain Loss On Available For Sale Marketable Securities
ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities
-1000
CY2020 dmtk Unpaid Deferred Issuance Costs
UnpaidDeferredIssuanceCosts
56000
CY2019 dmtk Unpaid Deferred Issuance Costs
UnpaidDeferredIssuanceCosts
1363000
CY2019 dmtk Debt Discount And Derivative Liability At Issuance Of Convertible Notes Payable
DebtDiscountAndDerivativeLiabilityAtIssuanceOfConvertibleNotesPayable
270000
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
441000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1228000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2525000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1188000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-20130000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-36477000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.87
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.15
CY2021 dmtk Net Change In Net Cash Used In Operating Activities
NetChangeInNetCashUsedInOperatingActivities
0
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:3.4%;white-space:nowrap" valign="top"> <p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">(</span><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">d</span><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">)</span></p></td> <td valign="top"> <p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:italic;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Use of Estimates </p></td></tr></table></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.4%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the amounts of revenues and expenses reported during the period. On an ongoing basis, management evaluates these estimates and judgments, including but not limited to, those related to assay revenue, stock-based compensation, short-term marketable securities, accounts receivable, warrant liability, right-of-use (“ROU”) assets and the realization of deferred tax assets. Actual results may differ from those estimates. </p>
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24248000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
176882000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15374000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24248000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4753000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15374000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3025000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24248000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
179907000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15374000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24248000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4753000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15374000
CY2021 us-gaap Depreciation
Depreciation
1000000.0
CY2020 us-gaap Depreciation
Depreciation
500000
CY2019 us-gaap Depreciation
Depreciation
100000
CY2021 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
100000
CY2020 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
100000
CY2019 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0
CY2019 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2020 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2020Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
109000
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:3.4%;white-space:nowrap" valign="top"> <p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">(</span><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">j</span><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">)</span></p></td> <td valign="top"> <p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:italic;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Concentration of Credit Risk </p></td></tr></table></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.4%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. As of December 31, 2021, the Company maintained $100.1 million in a sweep account, which maintains cash balances throughout various interest bearing bank accounts under the $250,000 insurance limit provided by the Federal Deposit Insurance Corporation for one federally insured financial institution. Approximately $60.2 million was held in excess of the Federal Deposit Insurance Corporation insured limit as of December 31, 2021. The Company has not experienced any losses in such accounts. </p>
CY2021Q4 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
100100000
CY2021Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
60200000
CY2021 dmtk Number Of Revenue Streams
NumberOfRevenueStreams
2
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11838000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5885000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3364000
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1400000
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
900000
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
600000
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
400000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1300000
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
38400000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13300000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5000000.0
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M29D
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
48573000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
125000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
48449000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
39530000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
8000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
39529000
CY2021Q4 dmtk Estimated Market Value Of Debt Securities With Contractual Maturities Of Less Than12 Months
EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months
21200000
CY2021Q4 dmtk Estimated Market Value Of Remaining Debt Securities With Contractual Maturities Of Up To23 Months
EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months
27200000
CY2020Q4 dmtk Estimated Market Value Of Debt Securities With Contractual Maturities Of Less Than12 Months
EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months
37300000
CY2020Q4 dmtk Estimated Market Value Of Remaining Debt Securities With Contractual Maturities Of Up To14 Months
EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo14Months
2300000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1801000
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1172000
CY2021Q4 dmtk Prepaid Trade Shows Current
PrepaidTradeShowsCurrent
440000
CY2021Q4 dmtk Prepaid Software Fees
PrepaidSoftwareFees
551000
CY2020Q4 dmtk Prepaid Software Fees
PrepaidSoftwareFees
214000
CY2020Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
56000
CY2021Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1074000
CY2020Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
727000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6174000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3418000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1625000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
687000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4549000
CY2021Q4 dmtk Prepaid Employee Compensation
PrepaidEmployeeCompensation
238000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
136000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
79000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3166000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1521000
CY2021Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
4805000
CY2020Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2544000
CY2021Q4 dmtk Computer Equipment Gross
ComputerEquipmentGross
171000
CY2020Q4 dmtk Computer Equipment Gross
ComputerEquipmentGross
38000
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
124000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2731000
CY2021Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
1245000
CY2020Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
606000
CY2021Q4 dmtk Accrued Bonus And Deferred Compensation Current
AccruedBonusAndDeferredCompensationCurrent
3875000
CY2020Q4 dmtk Accrued Bonus And Deferred Compensation Current
AccruedBonusAndDeferredCompensationCurrent
1469000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5120000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2075000
CY2021Q4 dmtk Accrued Consulting Services Current
AccruedConsultingServicesCurrent
775000
CY2020Q4 dmtk Accrued Consulting Services Current
AccruedConsultingServicesCurrent
285000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
452000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
478000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1227000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
763000
CY2019Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
2267042
CY2019Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
900000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
615385
CY2021Q1 dmtk Gross Proceeds From Offering Before Deducting Underwriting Discounts And Commissions And Other Offering Expenses
GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses
143700000
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
134600000
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4591
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
7332
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.048
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.049
CY2021 dmtk Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
0.011
CY2020 dmtk Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
-0.001
CY2019 dmtk Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
-0.008
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.006
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.004
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.002
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.004
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.005
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.271
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.257
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.204
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
46886000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
28422000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
20336000
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
2411000
CY2020Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
1631000
CY2019Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
1400000
CY2021Q4 dmtk Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
0
CY2020Q4 dmtk Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
14000
CY2019Q4 dmtk Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
33000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2126000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
653000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
119000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
719000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
422000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
194000
CY2021Q4 dmtk Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
1935000
CY2020Q4 dmtk Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
0
CY2019Q4 dmtk Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
0
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
340000
CY2020Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
0
CY2019Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
0
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
54417000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
31142000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
22082000
CY2021Q4 dmtk Deferred Tax Liabilities Depreciation And Amortization
DeferredTaxLiabilitiesDepreciationAndAmortization
32000
CY2020Q4 dmtk Deferred Tax Liabilities Depreciation And Amortization
DeferredTaxLiabilitiesDepreciationAndAmortization
0
CY2019Q4 dmtk Deferred Tax Liabilities Depreciation And Amortization
DeferredTaxLiabilitiesDepreciationAndAmortization
0
CY2021Q4 dmtk Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
1972000
CY2020Q4 dmtk Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
0
CY2019Q4 dmtk Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
0
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2004000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0
CY2021Q4 dmtk Deferred Tax Assets Liabilities Before Valuation Allowance
DeferredTaxAssetsLiabilitiesBeforeValuationAllowance
52413000
CY2020Q4 dmtk Deferred Tax Assets Liabilities Before Valuation Allowance
DeferredTaxAssetsLiabilitiesBeforeValuationAllowance
31142000
CY2019Q4 dmtk Deferred Tax Assets Liabilities Before Valuation Allowance
DeferredTaxAssetsLiabilitiesBeforeValuationAllowance
22082000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
52413000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
31142000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
22082000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2020Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2019Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2021Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2021 dmtk Percentage Of Useful Lives Of Assets
PercentageOfUsefulLivesOfAssets
0.75
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10000
CY2021Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
274000
CY2020Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
362000
CY2021Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
17000
CY2020Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
27000
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
257000
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
335000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
121000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
109000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
136000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
226000
CY2021 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
In January 2013, DermTech Operations entered into a non-cancelable lease agreement for its operating facilities in Torrey Pines (the “Torrey Lease”). In January 2014, DermTech Operations signed an amendment to the Torrey Lease to extend the term through January 2017. In November 2016, DermTech Operations signed a second amendment to the Torrey Lease to extend the term through March 2022. In August 2019, DermTech Operations signed a third amendment to the Torrey Lease to add additional space, and in September 2019, the Company signed a fourth amendment to the lease to add additional space. In February 2020, the Company signed a fifth amendment to the Torrey Lease to add additional space. In connection with the Business Combination, the Company assumed all obligations under the Torrey Lease, as amended, from DermTech Operations.
CY2021Q4 dmtk Tenant Improvement Allowance
TenantImprovementAllowance
300000
CY2021 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2023-04-30
CY2021 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
an option to extend the lease term on all leased space for one additional three-year term
CY2021Q1 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P28M
CY2021Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0404
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3100000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2800000
CY2021Q1 dmtk Tenant Improvement Allowance
TenantImprovementAllowance
300000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
1517000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
657000
CY2021 dmtk Operating Lease Costs
OperatingLeaseCosts
2174000
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
75000
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
17000
CY2021 dmtk Finance Lease Cost
FinanceLeaseCost
92000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
2619000
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
17000
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
171000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9044000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
93000
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0578
CY2021Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0563
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1802000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1149000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
688000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
709000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
730000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
4928000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10006000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
132000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
122000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
8000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
8000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
4000
CY2021Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
274000
CY2021Q4 dmtk Operating And Capital Lease Liability Payments Due Next Twelve Months
OperatingAndCapitalLeaseLiabilityPaymentsDueNextTwelveMonths
1934000
CY2021Q4 dmtk Operating And Capital Lease Liability Payments Due Year Two
OperatingAndCapitalLeaseLiabilityPaymentsDueYearTwo
1271000
CY2021Q4 dmtk Operating And Capital Lease Liability Payments Due Year Three
OperatingAndCapitalLeaseLiabilityPaymentsDueYearThree
696000
CY2021Q4 dmtk Operating And Capital Lease Liability Payments Due Year Four
OperatingAndCapitalLeaseLiabilityPaymentsDueYearFour
717000
CY2021Q4 dmtk Operating And Capital Lease Liability Payments Due Year Five
OperatingAndCapitalLeaseLiabilityPaymentsDueYearFive
734000
CY2021Q4 dmtk Operating And Capital Lease Liability Payments Due Thereafter
OperatingAndCapitalLeaseLiabilityPaymentsDueThereafter
4928000
CY2021Q4 dmtk Operating And Capital Lease Liability Payments Due
OperatingAndCapitalLeaseLiabilityPaymentsDue
10280000
CY2021 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
0
CY2019 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
0
CY2020 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
0

Files In Submission

Name View Source Status
0001564590-22-009635-index-headers.html Edgar Link pending
0001564590-22-009635-index.html Edgar Link pending
0001564590-22-009635.txt Edgar Link pending
0001564590-22-009635-xbrl.zip Edgar Link pending
dmtk-10k_20211231.htm Edgar Link pending
dmtk-10k_20211231_htm.xml Edgar Link completed
dmtk-20211231.xsd Edgar Link pending
dmtk-20211231_cal.xml Edgar Link unprocessable
dmtk-20211231_def.xml Edgar Link unprocessable
dmtk-20211231_lab.xml Edgar Link unprocessable
dmtk-20211231_pre.xml Edgar Link unprocessable
dmtk-ex231_8.htm Edgar Link pending
dmtk-ex311_9.htm Edgar Link pending
dmtk-ex312_6.htm Edgar Link pending
dmtk-ex321_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g4lv1dgrulou000001.jpg Edgar Link pending
g4lv1dgrulou000002.jpg Edgar Link pending
g4lv1dgrulou000003.jpg Edgar Link pending
g4lv1dgrulou000004.jpg Edgar Link pending
g4lv1dgrulou000005.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending